Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
Article in Drugs & Therapy Perspectives (February 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Drugs & Therapy Perspectives (February 2024)
Article in Frontiers in Psychiatry (July 2023)
Article in Pilot and Feasibility Studies (July 2023)